Centre Hospitalier De Versailles — Clinical Trial Site

121 Registered trials

56 Currently recruiting

Organisation

Centre Hospitalier De Versailles

Location

Le Chesnay Rocquencourt, France

Identifier

ORG-100010438

Address

177 Rue De Versailles, Le Chesnay, 78150, France

Departments

1207: Service d'Hematologie et d'Onc
125012: Service d'Hematologie et d'Onc
215:Service d'Hematologie et d'Onc
2213: Cardiology
78150
Adult Psychiatry
Cardiologie et médecine vasculaire
CARDIOLOGY
chirurgie digestive
Chirurgie digestive et oncologique
Chirurgie digestive et viscérale
Clinical hematology
Département d’Hématologie
Département de Cardiologie
Department of Hematology
Haematologu
Haematology
Hemato-Oncologie
Hématologie
Hématologie Oncologie
Hématologie-oncologie
Hematology
Hematology and Oncology
Hematology Department
Hematology/ Oncology Department
Hépato-entérogastrologie et endoscopie digestive
Hépato-gastro-entérologie
Hepato-gastroentorology
Hepatology and Gastroenterology
Hôpital André Mignot Département de Pneumologie
Hôpital André Mignot - Service d’Hépato-gastro-entérologie
Hôpital André Mignot_Service d’Hépato-gastro-entérologie
ICU
Intensive care
Intensive Care Unit
Maladies infectieuses
Medecine intensive care unit
Médecine intensive réanimation
Medical and Surgical ICU
Medical Oncology
medical-surgical intensive care
Neonatology Department
neurologie
Neurology
Onco-hématologie
Oncologie
ONCOLOGIE MEDICALE
Oncology
Pediatrics
Pédiatrie
Pneumologie
pneumology
Réanimation
Réanimation Médico-Chirurgicale
Réanimation polyvalente
SAMU 78
Service d hematologie et oncologie
Service d'hématologie
Service d'hématologie-oncologie
Service d’Hémato-Oncologie
Service d’Hématologie
Service d’Hématologie Clinique
Service de cardiologie
Service de neurologie
Service de Pneumologie
Service de Réanimation / Unité de Surveillance Continue
Service de Réanimation Médico-Chirurgicale
Service Hématologie
Service pediatrie

Clinical trials at this site (121)

Search interface

HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
A Phase 3 Study Comparing Lenalidomide and Daratumumab Subcutaneous Injection (R-Dara SC) vs Lenalidomide and Dexamethasone (Rd) in Frail Su… Ended

2024-514088-25-00 Multiple Myeloma 5 2019-10-07
OPEN LABEL PHASE 2 STUDY ON THE EFFICACY AND TOLERANCE OF A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN A… Ended

2024-516048-24-00 CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR I 4 2019-06-19
Study of the efficacy of treatment with AG-120 in patients with Myelodysplastic Syndrome and mutation IDH1 Ended

2024-515352-20-00 myelodysplastic syndrome with IDH1 mutated 4 2019-03-20
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
study of the efficacy of treatment with AG-221 in patients with myelodysplastic syndrome and mutation IDH2 Ended

2024-513858-29-01 myelodysplastic syndrome with IDH2 mutated 4 2019-02-06
An Efficacy Study Comparing Ponatinib Versus Imatinib, Administered in Combination with Reduced-Intensity Chemotherapy, in Participants with… Ended

2023-508463-71-00 Newly Diagnosed Philadelphia Chromosome-Positive Acute 5 2018-11-30
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection Ended

2024-510704-37-00 ER+/HER2- metastatic breast cancer 5 2017-03-22
PIO2STOP_Combination study of Pioglitazone and Tyrosine Kinase Inhibitors (TKIs) in Chronic Myeloid Leukemia patients after failure of a TKI… Ended

2024-515460-31-00 CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA 4 2016-11-07
Efficacy of early intravenous high-dose vitamin C in post-cardiac arrest shock: a multicenter, randomized controled to standard treatment, o… Halted

2022-500717-64-00 cardiac arrest 4 2023-12-27
A phase 1/2 study of subcutaneous blinatumomab administration in adults and adolescents with R/R and MRD+ B-ALL Halted

2023-506136-32-00 Relapsed or Refractory B cell Precursor Acute Lymphobla 9 2020-10-12
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
Detection of tumor DNA in the blood of patients receiving standard therapy for hormone receptorpositive (HR+) non-HER2 expressing (HER2-) me… Ended

2022-502372-22-01 Metastatic Breast Cancer HR+, HER2- 4 2023-10-19
A study to test the safety of MK-1654 and how well MK-1654 works in healthy infants Ended

2022-500350-42-01 Prevention of RSV 10 2022-11-07
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08
Tamibarotene/Venetoclax/Azacitidine in Previously Untreated Patients Selected for RARA-positive AML (SELECT-AML-1) Ended

2024-510939-21-00 RARA-positive acute myeloid leukemia 4 2022-04-01
Palivizumab-Controlled Evaluation of Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe … Ended

2022-500752-39-00 Prevention of Respiratory syncytial virus (RSV) infecti 5 2021-11-25
Efficacy of Tocilizumab in association to steroids in giant cell arteritis with cerebro-vascular involvement patients (ToGiAS). A french pro… Ended

2024-511906-21-00 Giant cell arteritis with Cerebro-vascular involvement 5 2021-09-24
EFRAIM II _ Empirical steroids and/or antifungals treatment of immunocompromised patients with acute respiratory failure of uknown origin: a… Ended

2024-514344-82-00 patients with acute respiratory failure from undetermin 5 2021-02-18
Adjunctive DobutAmine in sePtic cardiomyopathy with Tissue hypoperfusion: a randomized controlled multi-center trial Ended

2024-517839-50-00 sepsis 11 2020-09-20
Rapid rEcognition of COrticosteroid Resistant or sentive Sepsis - RECORDS Ended

2024-516407-16-00 Patients admitted to the ICU proven or suspected infect 5 2020-04-10
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
Trial comparing the continuation of nivolumab and ipilimumab (doublet immunotherapy) to observation after a first 6 months treatment by nivo… Ended

2024-514586-20-01 Non small cell lung cancer 5 2018-05-02
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Can… Ended

2024-517856-36-00 Completely resected primary stage IB (≥ 4cm), II and II 5 2015-03-09